Founded in August 1996 and renamed Chongqing Aoli biopharmaceutical Co., Ltd. in 2003, the company is a national high-tech enterprise and a municipal science and technology enterprise. It is located in Shanghai Industrial Park, National Economic Development Zone, Wanzhou District, Chongqing, covering an area of 80 mu, with convenient transportation and beautiful environment. Chen Zeng, the legal representative of the company, graduated from the Department of Business Administration of Warwick University, UK, with a master's degree. He is now the general manager of the company. The company approved the establishment of a municipal enterprise technology R & D center in 2012. Based on the advantages of rich raw material resources in China, the center focuses on the research and development of natural active ingredients in animal and plant organs and tissues, focusing on the R & D and production of proteins, enzymes and polysaccharides; The center has advanced R & D instruments and perfect testing means, and can independently engage in drug R & D and testing. The center has 18 professional technicians, including 1 master's student and 15 undergraduates. The company has a number of employees who have received professional training and practical work experience, and professional technicians account for 60% of the total number of employees. The company passed the new version of GMP certification in November 2019. The production plant is designed and built in strict accordance with the national GMP standards. The existing production plant is more than 7200 square meters and office and other supporting rooms are more than 3000 square meters. There are 3 API production lines, 1 tablet production line, 1 capsule production line and 1 granule production line; The annual output of API is 500 tons. The leading products include trypsin, pepsin, gastrin, sodium chondroitin sulfate, etc. the product quality meets the standards of CP, USP, EP, BP and JP, and is exported to America, Europe, Southeast Asia and other regions; Annual production capacity of preparations: 2 billion tablets, 1 billion capsules and 1 billion bags of granules. The varieties of preparations produced include multienzyme tablets, pepsin tablets, elastase enteric coated tablets, pancreatin enteric coated capsules, etc. Based on the production and business philosophy of "innovation, cooperation, integrity and win-win", the company sincerely hopes that customers at home and abroad will call and write to negotiate business and cooperate hand in hand.